← FDA DRUG APPROVALS
FDA ANDA · ANDA065027
CLINDAMYCIN PHOSPHATE IN DEXTROSE 5% IN PLASTIC CONTAINER
Sponsor: ABBOTT LABS
APPLICATION
ANDA065027
TYPE
ANDA
ORIGINAL APPROVAL
2001-06-29
LATEST ACTION
2002-09-13
ROUTE
INJECTION
DOSAGE FORM
INJECTABLE
MARKETING STATUS
Discontinued
Products
CLINDAMYCIN PHOSPHATE IN DEXTROSE 5% IN PLASTIC CONTAINERDiscontinued
CLINDAMYCIN PHOSPHATE EQ 18MG BASE/ML · INJECTABLE · INJECTION
CLINDAMYCIN PHOSPHATE IN DEXTROSE 5% IN PLASTIC CONTAINERDiscontinued
CLINDAMYCIN PHOSPHATE EQ 6MG BASE/ML · INJECTABLE · INJECTION
CLINDAMYCIN PHOSPHATE IN DEXTROSE 5% IN PLASTIC CONTAINERDiscontinued
CLINDAMYCIN PHOSPHATE EQ 12MG BASE/ML · INJECTABLE · INJECTION
Approval history
2002-09-13Manufacturing (CMC) · Supplement 1AP
2002-09-13Manufacturing (CMC) · Supplement 2AP
Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.
Weekly Briefing
Read a past issue →Get the Weekly GxP Briefing
Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.